Insulin resistance in pulmonary arterial hypertension
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Although obesity, dyslipidemia and insulin resistance (IR) are well known risk factors for systemic cardiovascular disease, their impact on pulmonary arterial hypertension (PAH) is unknown. The present authors’ previous studies indicate that IR may be a risk factor for PAH. The current study has investigated the prevalence of IR in PAH and explored its relationship with disease severity. Clinical data and fasting blood samples were evaluated in 81 nondiabetic PAH females. In total, 967 National Health and Nutrition Examination Surveys (NHANES) females served as controls. The fasting triglyceride to high-density lipoprotein cholesterol ratio was used as a surrogate of insulin sensitivity. While body mass index was similar in NHANES versus PAH females (28.6 versus 28.7 kg·m−2), PAH females were more likely to have IR (45.7 versus 21.5%) and less likely to be insulin sensitive (IS; 43.2 versus 57.8%). PAH females mostly (82.7%) had New York Heart Association (NYHA) class II and III symptoms. Aetiology, NYHA class, 6-min walk-distance and haemodynamics did not differ between IR and IS PAH groups. However, the presence of IR and a higher NYHA class was associated with poorer 6-months event-free survival (58 versus 79%). Insulin resistance appears to be more common in pulmonary arterial hypertension females than in the general population, and may be a novel risk factor or disease modifier that might impact on survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Self-citationEckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
Eckel, R. H., Grundy, S. M., & Zimmet, P. Z. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66378-7 · Cited by 5,550
Banting lecture 1988. Role of insulin resistance in human disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diabetes.37.12.1595 · Cited by 3,811
Self-citationObesity and the Metabolic Syndrome in Children and Adolescents
Weiss, R., Dziura, J., Burgert, T. S., Tamborlane, W. V., Taksali, S. E., Yeckel, C. W., Allen, K., Lopes, M., Savoye, M., Morrison, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031049 · Cited by 3,459
The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure.
Guyatt, G. H., Sullivan, M. J., Thompson, P. J., Fallen, E. L., Pugsley, S. O., Taylor, D. W., & Berman, L. (1985) · Europe PMC (PubMed Central) · Cited by 2,401
Expression of Endothelin-1 in the Lungs of Patients with Pulmonary Hypertension
Giaid, A., Yanagisawa, M., Langleben, D., Michel, R. P., Levy, R., Shennib, H., Kimura, S., Masaki, T., Duguid, W. P., & Stewart, D. J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306173282402 · Cited by 1,842
Cellular and molecular pathobiology of pulmonary arterial hypertension
Humbert, M., Morrell, N. W., Archer, S. L., Stenmark, K. R., MacLean, M. R., Lang, I. M., Christman, B. W., Weir, E. K., Eickelberg, O., Voelkel, N. F., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.02.029 · Cited by 1,576
Self-citationGrundy, S. M. (2011) · Atlas of Atherosclerosis and Metabolic Syndrome · doi:10.1007/978-1-4419-5839-6_1 · Cited by 1,223
Appetite-suppressant drugs and the risk of primary pulmonary hypertension
Abenhaim, L., Moride, Y., Brenot, F., Rich, S., Benichou, J., Kurz, X., Higenbottam, T., Oakley, C., Wouters, E., Aubier, M., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608293350901 · Cited by 1,162
Use of metabolic markers to identify overweight individuals who are insulin resistant
McLaughlin, T., Abbasi, F., Cheal, K., Chu, J., Lamendola, C., & Reaven, G. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-10-200311180-00007 · Cited by 1,022
Self-citationBeltrán‐Aguilar, E. D. (2005) · Medical Entomology and Zoology · Cited by 908
Ferrannini, E., Natali, A., Bell, P., Cavallo-Perin, P., Lalic, N., & Mingrone, G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119628 · Cited by 898 · cited 1×
“Obesity has been associated with insulin resistance in non-diabetic, normotensive subjects [6-8].”
BackgroundHaffner, S. M., Greenberg, A. S., Weston, W. M., Chen, H., Williams, K., & Freed, M. I. (2002) · Circulation · doi:10.1161/01.cir.0000025403.20953.23 · Cited by 884
Humbert, M., Monti, G., Brenot, F., Sitbon, O., Portier, A., Grangeot-Keros, L., Duroux, P., Galanaud, P., Simonneau, G., & Emilie, D. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.5.7735624 · Cited by 797
Mereles, D., Ehlken, N., Kreuscher, S., Ghofrani, S., Hoeper, M. M., Halank, M., Meyer, F. J., Karger, G., Buss, J., Juenger, J., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.618397 · Cited by 729
Relationship Between Insulin Resistance and an Endogenous Nitric Oxide Synthase Inhibitor
Stühlinger, M. C. (2002) · JAMA · doi:10.1001/jama.287.11.1420 · Cited by 581
Insulin Resistance and Risk of Congestive Heart Failure
Ingelsson, E., Sundström, J., Ärnlöv, J., Zethelius, B., & Lind, L. (2005) · JAMA · doi:10.1001/jama.294.3.334 · Cited by 573
Appetite-suppressant drugs and the risk of primary pulmonary hypertension
(1997) · ACC Current Journal Review · doi:10.1016/s1062-1458(97)89579-7 · Cited by 562
Yudkin, J. S., Eringa, E., & Stehouwer, C. D. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66585-3 · Cited by 549
Insulin Resistance in Chronic Heart Failure: Relation to Severity and Etiology of Heart Failure
Swan, J. W., Anker, S. D., Walton, C., Godsland, I. F., Clark, A. L., Leyva, F., Stevenson, J. C., & Coats, A. J. S. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00185-x · Cited by 533
Marx, N., Duez, H., Fruchart, J.-C., & Staels, B. (2004) · Circulation Research · doi:10.1161/01.res.0000127122.22685.0a · Cited by 501
Combs, C. K., Johnson, D. E., Karlo, J. C., Cannady, S. B., & Landreth, G. E. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-02-00558.2000 · Cited by 483
Prevalence of Diabetes and Impaired Fasting Glucose in the Adult Population of Iran
Esteghamati, A., Gouya, M. M., Abbasi, M., Delavari, A., Alikhani, S., Alaedini, F., Safaie, A., Forouzanfar, M., & Gregg, E. W. (2008) · Diabetes Care · doi:10.2337/dc07-0959 · Cited by 384
Hansmann, G., de Jesus Perez, V. A., Alastalo, T.-P., Alvira, C. M., Guignabert, C., Bekker, J. M., Schellong, S., Urashima, T., Wang, L., Morrell, N. W., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32503 · Cited by 367
Self-citationHansmann, G., Wagner, R. A., Schellong, S., de Jesus Perez, V. A., Urashima, T., Wang, L., Sheikh, A. Y., Suen, R. S., Stewart, D. J., & Rabinovitch, M. (2007) · Circulation · doi:10.1161/circulationaha.106.663120 · Cited by 366
Self-citationScreening Women With Polycystic Ovary Syndrome for Metabolic Syndrome
Dokras, A., Bochner, M., Hollinrake, E., Markham, S., VanVoorhis, B., & Jagasia, D. H. (2005) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000167408.30893.6b · Cited by 353
Relationship between degree of obesity and in vivo insulin action in man
Bogardus, C., Lillioja, S., Mott, D. M., Hollenbeck, C., & Reaven, G. (1985) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1985.248.3.e286 · Cited by 344
Self-citationDoehner, W., Rauchhaus, M., Ponikowski, P., Godsland, I. F., von Haehling, S., Okonko, D. O., Leyva, F., Proudler, A. J., Coats, A. J. S., & Anker, S. D. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.02.093 · Cited by 294 · cited 5×
“However, similar to patients with CHF, IR in the current study was associated with poorer survival (fig.”
BackgroundInfluentialSuskin, N. (2000) · European Heart Journal · doi:10.1053/euhj.1999.2043 · Cited by 271 · cited 5×
“However, similar to patients with CHF, IR in the current study was associated with poorer survival (fig.”
BackgroundInfluentialMcLaughlin, T., Allison, G., Abbasi, F., Lamendola, C., & Reaven, G. (2004) · Metabolism · doi:10.1016/j.metabol.2003.10.032 · Cited by 268 · cited 1×
“Obesity has been associated with insulin resistance in non-diabetic, normotensive subjects [6-8].”
BackgroundSelf-citationRole of Endothelium-derived CC Chemokine Ligand 2 in Idiopathic Pulmonary Arterial Hypertension
Sanchez, O., Marcos, E., Perros, F., Fadel, E., Tu, L., Humbert, M., Dartevelle, P., Simonneau, G., Adnot, S., & Eddahibi, S. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200610-1559oc · Cited by 228
Asymmetrical Dimethylarginine in Idiopathic Pulmonary Arterial Hypertension
Kielstein, J. T., Bode-Böger, S. M., Hesse, G., Martens-Lobenhoffer, J., Takacs, A., Fliser, D., & Hoeper, M. M. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000168414.06853.f0 · Cited by 220
Insulin resistance and impaired beta cell function in rheumatoid arthritis
Dessein, P. H., & Joffe, B. I. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22053 · Cited by 218
Anorexigens and Pulmonary Hypertension in the United States
Rich, S., Rubin, L., Walker, A. M., Schneeweiss, S., & Abenhaim, L. (2000) · Chest · doi:10.1378/chest.117.3.870 · Cited by 189
Pulmonary hypertension surveillance--United States, 1980-2002.
Hyduk, A., Croft, J. B., Ayala, C., Zheng, K. H., Zheng, Z., & Mensah, G. A. (2005) · PubMed · Cited by 179
Relationship between Serum Lipoprotein Ratios and Insulin Resistance in Obesity
Brehm, A., Pfeiler, G., Pacini, G., Vierhapper, H., & Roden, M. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.037556 · Cited by 167
Hadaegh, F., Khalili, D., Ghasemi, A., Tohidi, M., Sheikholeslami, F., & Azizi, F. (2009) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2008.09.003 · Cited by 161
Wang, T., Chen, W., Lin, J., Chen, M.-F., & Lee, Y. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.10.022 · Cited by 151
Insulin resistance in idiopathic dilated cardiomyopathy
Witteles, R. M., Tang, W. H. W., Jamali, A. H., Chu, J. W., Reaven, G. M., & Fowler, M. B. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.03.037 · Cited by 117
Self-citationAnti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary hypertension in rats
Ikeda, Y., Yonemitsu, Y., Kataoka, C., Kitamoto, S., Yamaoka, T., Nishida, K.-I., Takeshita, A., Egashira, K., & Sueishi, K. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00919.2001 · Cited by 114
Dengel, D. R., Hagberg, J. M., Pratley, R. E., Rogus, E. M., & Goldberg, A. P. (1998) · Metabolism · doi:10.1016/s0026-0495(98)90281-5 · Cited by 110
Primary Pulmonary Hypertension Associated With the Use of Fenfluramine Derivatives
Simonneau, G., Fartoukh, M. S., Sitbon, O., Humbert, M. J. C., Jagot, J.-L., & Hervé, P. (1998) · CHEST Journal · doi:10.1378/chest.114.3_supplement.195s · Cited by 108
Engelson, E. S., Agin, D., Kenya, S., Werber-Zion, G., Luty, B., Albu, J., & Kotler, D. P. (2006) · Metabolism · doi:10.1016/j.metabol.2006.05.018 · Cited by 105
Martin‐Nizard, F., Furman, C., Delerive, P., Kandoussi, A., Fruchart, J., Staels, B., & Duriez, P. (2002) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200212000-00003 · Cited by 99
The humoral side of insulin resistance
Lazar, M. A. (2006) · Nature Medicine · doi:10.1038/nm0106-43 · Cited by 95
Escarcega, R. O., García‐Carrasco, M., Fuentes-Alexandro, S. A., Jara, L. J., Rojas-Rodríguez, J., Escobar-Linares, L. E., & Cervera, R. (2006) · Autoimmunity Reviews · doi:10.1016/j.autrev.2006.07.001 · Cited by 76
Li, C., Ford, E. S., McGuire, L., & Mokdad, A. H. (2006) · Journal of Epidemiology & Community Health · doi:10.1136/jech.2006.048173 · Cited by 76
Evidence for peripheral impaired glucose handling in patients with connective tissue diseases
Paolisso, G., Valentini, G., Giugliano, D., Marrazzo, G., Tirri, R., Gallo, M., Tirri, G., Varricchio, M., & D’Onofrio, F. (1991) · Metabolism · doi:10.1016/0026-0495(91)90064-4 · Cited by 67
Severe pulmonary hypertension in postmenopausal obese women.
Taraseviciute, A., & Voelkel, N. F. (2006) · PubMed · Cited by 67
Chu, J. W., Abbasi, F., Lamendola, C. A., McLaughlin, T., Reaven, G. M., & Tsao, P. S. (2005) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2005.004 · Cited by 38
Self-citationHigh incidence of primary pulmonary hypertension associated with appetite suppressants in Belgium
Delcroix, M., Kurz, X., Walckiers, D., DEMEDTS, M. G., & Naeije, R. (1998) · European Respiratory Journal · doi:10.1183/09031936.98.12020271 · Cited by 37
Effect of bosentan (ET/ET receptor antagonist) on metabolic changes during stress and diabetes
SAID, S., Ammar, E. M., & Suddek, G. M. (2005) · Pharmacological Research · doi:10.1016/j.phrs.2004.05.009 · Cited by 20
Effects of hiking at altitude on body composition and insulin sensitivity in recovering drug addicts
Lee, W. C. (2004) · Preventive Medicine · doi:10.1016/j.ypmed.2004.02.035 · Cited by 17
Effect of Physical Training on Insulin Resistance in Patients With Chronic Heart Failure
Nishiyama, Y., Minohara, M., Ohe, M., Hirai, Y., Katoh, A., Miyamoto, T., Iwami, G., Nakata, M., & Koga, Y. (2006) · Circulation Journal · doi:10.1253/circj.70.864 · Cited by 15
Cited by
Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension
Rabinovitch, M., Guignabert, C., Humbert, M., & Nicolls, M. R. (2014) · Circulation Research · doi:10.1161/circresaha.113.301141 · Cited by 1,029
Self-citationMolecular pathogenesis of pulmonary arterial hypertension
Rabinovitch, M. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33452 · Cited by 880
Self-citationMolecular pathogenesis of pulmonary arterial hypertension
Rabinovitch, M. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60658 · Cited by 653
Self-citationMichelakis, E. D., Gurtu, V., Webster, L., Barnes, G., Watson, G., Howard, L., Cupitt, J., Paterson, I., Thompson, R. B., Chow, K., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aao4583 · Cited by 316
The Metabolic Theory of Pulmonary Arterial Hypertension
Paulin, R., & Michelakis, E. D. (2014) · Circulation Research · doi:10.1161/circresaha.115.301130 · Cited by 314
Metadata
- Authors
- Zamanian, R. T., Hansmann, G., Snook, S., Lilienfeld, D., Rappaport, K. M., Reaven, G. M., Rabinovitch, M., & Doyle, R. L.
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2008-12-01
- Volume
- 33
- Issue
- 2
- Pages
- 318-324
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2095314259
- Cited by
- 273
- References
- 55
- FWCI
- 6.96
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.